Various membrane proteins and lipids

Various membrane proteins and lipids is a collective term used to describe the broad array of molecular components that constitute cellular and organellar membranes, including phospholipids, cholesterol, and integral or peripheral membrane proteins (Source: Alberts et al., Molecular Biology of the Cell, 2002). This designation is frequently applied in pharmacology when a drug's therapeutic effect is mediated through the non-specific perturbation of membrane structure or the simultaneous modulation of multiple membrane-bound entities rather than a single, specific receptor (Source: Franks, N. P., Nature Reviews Neuroscience, 2008). For example, general anesthetics like isoflurane and certain antibiotics like daptomycin or colistin interact with these components to alter membrane fluidity, permeability, or electrochemical gradients (Source: StatPearls, "General Anesthesia", 2023; PubMed, PMCID: PMC4264182). Antifungal agents such as amphotericin B specifically target lipid components like ergosterol to induce pore formation and cell death (Source: StatPearls, "Amphotericin B", 2023). Because this category encompasses thousands of distinct molecules, it is not considered a single therapeutic target but rather a functional environment or a multi-target grouping. Drugs targeting these components often face challenges related to systemic toxicity and a lack of cellular selectivity due to the fundamental role of membranes in all living cells (Source: Journal of Biological Chemistry, 2017). Consequently, this classification is often used for agents with pleiotropic or poorly defined mechanisms of action where specific protein-ligand interactions have not been isolated.

Other names

Cell membrane componentsMembrane constituentsPlasma membrane proteins and lipidsMembrane lipids and proteins

Non-specific disruption of membrane integrity, alteration of lipid bilayer fluidity, and modulation of multiple membrane-embedded protein functions (Source: Nature Reviews Neuroscience, 2008; StatPearls, 2023).